These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 28983668
1. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts. Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF. J Bone Miner Metab; 2018 Sep; 36(5):508-518. PubMed ID: 28983668 [Abstract] [Full Text] [Related]
2. Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis. Kuo YJ, Tsuang FY, Sun JS, Lin CH, Chen CH, Li JY, Huang YC, Chen WY, Yeh CB, Shyu JF. PLoS One; 2012 Sep; 7(7):e40272. PubMed ID: 22792258 [Abstract] [Full Text] [Related]
3. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats. Yuan H, Xiao L, Min W, Yuan W, Lu S, Huang G. J Ethnopharmacol; 2018 Jun 28; 220():228-238. PubMed ID: 29317302 [Abstract] [Full Text] [Related]
4. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats. Jin X, Zhu L, Li X, Jia J, Zhang Y, Sun X, Ma J, Liu Z, Ma X. Mol Med Rep; 2017 Feb 28; 15(2):890-898. PubMed ID: 28000877 [Abstract] [Full Text] [Related]
5. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats. Peng S, Zhang G, Zhang BT, Guo B, He Y, Bakker AJ, Pan X, Zhen W, Hung L, Qin L, Leung WN. Bone; 2013 Jul 28; 55(1):230-40. PubMed ID: 23486180 [Abstract] [Full Text] [Related]
6. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats. Hsiao CY, Chen TH, Chu TH, Ting YN, Tsai PJ, Shyu JF. Front Endocrinol (Lausanne); 2020 Jul 28; 11():613. PubMed ID: 33013696 [Abstract] [Full Text] [Related]
7. Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate. Thaler R, Maurizi A, Roschger P, Sturmlechner I, Khani F, Spitzer S, Rumpler M, Zwerina J, Karlic H, Dudakovic A, Klaushofer K, Teti A, Rucci N, Varga F, van Wijnen AJ. J Biol Chem; 2016 Mar 25; 291(13):6754-71. PubMed ID: 26757819 [Abstract] [Full Text] [Related]
11. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin. Choudhary D, Kushwaha P, Gautam J, Kumar P, Verma A, Kumar A, Maurya SW, Siddiqui IR, Mishra PR, Maurya R, Trivedi R. Biomed Pharmacother; 2016 Oct 25; 83():942-957. PubMed ID: 27522257 [Abstract] [Full Text] [Related]
12. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Jobke B, Milovanovic P, Amling M, Busse B. Bone; 2014 Feb 25; 59():37-43. PubMed ID: 24211427 [Abstract] [Full Text] [Related]
13. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J. J Bone Miner Res; 2012 Jun 25; 27(6):1298-1308. PubMed ID: 22337253 [Abstract] [Full Text] [Related]
14. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway. Li F, Sun X, Ma J, Ma X, Zhao B, Zhang Y, Tian P, Li Y, Han Z. Biochem Biophys Res Commun; 2014 Sep 26; 452(3):629-35. PubMed ID: 25181344 [Abstract] [Full Text] [Related]
16. Fluorine-contained hydroxyapatite suppresses bone resorption through inhibiting osteoclasts differentiation and function in vitro and in vivo. Liu S, Zhou H, Liu H, Ji H, Fei W, Luo E. Cell Prolif; 2019 May 25; 52(3):e12613. PubMed ID: 30968984 [Abstract] [Full Text] [Related]
19. Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects. Yao Z, Ayoub A, Srinivasan V, Wu J, Tang C, Duan R, Milosavljevic A, Xing L, Ebetino FH, Frontier AJ, Boyce BF. Bone Res; 2024 Sep 05; 12(1):52. PubMed ID: 39231935 [Abstract] [Full Text] [Related]
20. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE. J Bone Miner Res; 2009 Feb 05; 24(2):209-20. PubMed ID: 18847326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]